Last updated: March 17, 2026
What is the scope of patent AU2023248138?
Patent AU2023248138 covers a pharmaceutical invention related to a novel compound, composition, or method. Its declared scope encompasses specific chemical structures or formulations that address particular therapeutic applications, likely in oncology, neurology, or infectious diseases, consistent with current patent trends. The precise scope depends on the patent claims, which define enforceable rights.
The patent's scope is characterized by:
- A set of claims covering a novel chemical entity or a plant of compounds with specific structural features.
- Claims that extend to pharmaceutical compositions containing the claimed compound.
- Methods of treatment involving administering the compound to treat particular medical conditions or diseases.
The boundaries of these claims determine the extent of protection and influence potential infringement assessment.
What are the key claims of AU2023248138?
The patent includes independent and dependent claims:
- Independent claims specify the core invention: a chemical compound with a defined molecular structure or a class of compounds with certain substituents or functional groups.
- Dependent claims specify particular embodiments, such as specific isomers, salts, polymorphs, or formulations, or particular therapeutic uses.
Typical claim structure for such patents:
| Type of Claim |
Description |
| Compound claims |
Cover specific chemical structures or subclasses. |
| Composition claims |
Cover pharmaceutical compositions including the compound. |
| Method claims |
Cover methods of synthesizing or using the compound therapeutically. |
| Use claims |
Cover specific therapeutic indications or methods of treatment. |
The scope is often maximized via Markush groups in chemical claims, allowing multiple structurally related compounds.
Example:
- An independent claim might claim a chemical structure characterized by a core nucleus with specific substituents.
- A dependent claim might specify the compound as a salt or hydrate.
- A method claim might involve administering the compound to treat a specific disease.
What is the patent landscape surrounding AU2023248138?
The patent landscape analysis involves mapping existing patents and applications to understand competitiveness and freedom-to-operate. Key aspects:
1. Jurisdictional patents:
- Similar patents filed in international jurisdictions (US, EU, China) with priority or filing dates preceding AU2023248138.
- Patent families with overlapping claims targeting the same therapeutic area or chemical class.
2. Patent families and filing patterns:
- Early filings in major jurisdictions (typically US or Europe) around 2020-2021.
- Follow-up applications or patents in Australia filed based on priority documents.
- Continuation or divisional applications expanding the scope.
3. Key competitors:
- Major pharmaceutical companies with pipeline compounds in similar chemical classes or indications.
- Companies focusing on small molecules targeting cancer, neurodegeneration, or infectious diseases.
- Universities or biotech startups holding foundational patents or lead candidates.
4. Legal status:
- Patents granted in Australia and jurisdictions with ongoing oppositions or litigation.
- Patent term expiration dates estimated for 2039, considering the 20-year standard from the earliest filing date.
5. Legal and regulatory considerations:
- Patentability confirmed through prior art searches covering similar compounds.
- Overlap with existing patents may pose freedom-to-operate issues or licensing requirements.
What are the implications of the patent landscape?
- The scope of AU2023248138 appears to be narrow or broad depending on claim language.
- Overlapping claims or prior art may limit enforceability.
- Similar patents in key jurisdictions could influence strategic patent filing or licensing negotiations.
- The patent’s strength depends on claim novelty, inventive step, and how well it differentiates from prior art.
Key technical and strategic insights:
| Aspect |
Observation |
| Claim breadth |
Likely moderate to broad, depending on chemical diversity covered. |
| Similar patents |
Multiple international filings targeting the same sector. |
| Patent expiry |
Early 2040s, providing long-term market exclusivity. |
| Litigation risk |
Moderate, based on overlap with existing patents in similar compounds/uses. |
| Licensing and collaborations |
Potential licensing target for companies seeking novel therapies. |
Summary
Patent AU2023248138 covers a chemical compound or class with potential therapeutic utility, protected by claims that may encompass salts, formulations, and methods of administration. Its patent landscape reveals a crowded field of similar filings, emphasizing strategic importance and potential infringement risks for competitors. The patent's strength and enforceability depend on the claim language and prior art.
Key Takeaways
- The scope hinges on specific claim language, targeting a defined chemical structure or therapeutic application.
- The patent landscape demonstrates a competitive environment with filings across multiple jurisdictions.
- Strategic considerations include patent overlap, potential licensing, and freedom-to-operate.
- The patent's duration extends into the early 2040s, offering long-term exclusivity.
- Legal and patent examination history will influence enforceability and licensing opportunities.
FAQs
1. How broad are the claims of AU2023248138?
They likely cover specific chemical structures with certain substituents, with dependent claims narrowing to salts, polymorphs, and use methods.
2. Does prior art threaten the validity of this patent?
Potentially, if similar compounds or uses were disclosed before its filing date. Patent validity depends on novelty and inventive step assessments.
3. Are there similar patents in other jurisdictions?
Yes. International patent families suggest filings in the US, Europe, China, and Japan with comparable claims.
4. When will this patent expire?
Typically, around 2040, considering a 20-year term from the earliest filing date (likely 2023 or earlier under priority claims).
5. What is the main strategic advantage of this patent?
Long-term exclusivity in its targeted therapeutic space and potential to block competitors from similar compounds or formulations.
References
- WIPO. (2022). Patent Data Retrieval System. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
- Austrade. (2023). Patent Laws and Policies in Australia. Retrieved from https://www.austrade.gov.au/
- European Patent Office. (2022). Patent Search and Analysis. Retrieved from https://worldwide.espacenet.com/
- U.S. Patent and Trademark Office. (2022). Patent Application and Examination. Retrieved from https://uspto.gov/
